Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSUMM.L Share News (SUMM)

  • There is currently no data for SUMM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sector movers: AstraZeneca, Shire lift pharma stocks on upbeat guidance

Tue, 14th Jan 2014 15:22

Decent gains from AstraZeneca and Shire gave the pharmaceuticals sector a boost on Tuesday as both firms gave confident outlooks.At the JP Morgan Healthcare Conference in San Francisco, AstraZeneca Chief Executive Pascal Soriot said he expects the company to return to growth sooner than analysts currently predict. He said that new incoming drugs from the company's portfolio as well as the buy-out of Bristol-Myers Squibb from their diabetes alliance should help halt a decline in sales. Sales have been under pressure over the last year due to a number of patent expiries and competition from generic versions of its drugs."AstraZeneca now expects 2017 revenues to be broadly in line with 2013 revenues," he said.The share price was 2.5% higher at around 3,755p by 15:50 on Tuesday.Toby Morris, Senior Sales Trader at CMC Markets, said: "The update comes ahead of a 2013 number release on Feb 6th, with a strong pipeline versus 12 months ago providing a boost in optimism and sending the stock higher."Shire, meanwhile, raised its earnings guidance for 2013 to the upper end of previous expectations, pushing the stock up 2.4% to 2,981p.Shire shares spiked immediately higher this afternoon as the Dublin-headquartered company put out a short statement from Chief Executive Flemming Ornskov that confirmed a strong finish to the year.Ornskov, who had been addressing investors at the same conference in San Francisco as AstraZeneca's Soriot, also added that he remained confident the company would deliver earnings for 2014 in line with the November 2013 consensus forecast (excluding ViroPharma).Others in the sector including Summit Corporation, Futura Medical and Skyepharma were making decent gains today.Vectura was also higher after the respiratory development company confirmed that its partner Sandoz has received Swedish marketing approval for their inhaler product AirFluSal Forspiro. Top performing sectors so far todayTechnology Hardware & Equipment 1,176.48 +1.16%Pharmaceuticals & Biotechnology 11,859.30 +0.85%Industrial Transportation 3,342.59 +0.78%Media 6,494.69 +0.73%Household Goods & Home Construction 11,269.09 +0.71%Bottom performing sectors so far todayElectronic & Electrical Equipment 4,505.01 -1.25%Industrial Metals & Mining 1,291.41 -1.24%Financial Services 7,863.20 -1.08%Oil & Gas Producers 8,257.45 -1.01%Forestry & Paper 10,922.16 -0.98%BC
More News
11 Jun 2015 12:28

Summit Therapeutics first-quarter pre-tax loss widens

Drug discovery and development company Summit Therapeutics posted a 52.6% widening in its first-quarter pre-tax loss, pointing to the cost of listing on the NASDAQ and higher research and development costs. The pre-tax losses came in at $5.8m compared with $3.8m in the same period last year. In the

Read more
11 Jun 2015 11:25

Summit Therapeutics First Quarter Loss Widens On Higher Costs

Read more
20 May 2015 19:18

BUZZ-Sarepta news lifts other muscular distrophy stocks

** Companies developing muscular distrophy treatments, PTC Therapeutics and Summit Therapeutics had their shares boosted on Wednesday by positive regulatory news from a third firm in the same space, Sarepta Therapeutics ** PTC shares rose as much as 7.2 percent during the session and were

Read more
30 Mar 2015 12:15

Port Erin Biopharma Swings To First Half Loss As Gains Do Not Recur

Read more
5 Mar 2015 15:15

BUZZ-Summit Therapeutics Plc: Shares rise in debut

** Biopharmaceutical company's U.S.-listed shares up 2.7 pct at $10.20 ** Stock rises as much as 4.5 pct to $10.35, valuing company at $120.8 mln ** Offering of 3.45 American depository shares priced at $9.90 each ** IPO raised about $34.15 mln

Read more
19 Feb 2015 08:34

UK MORNING BRIEFING: Centrica Shares Fall 7.7% On Loss, Dividend Cut

Read more
19 Feb 2015 06:23

UK AGM, EGM Calendar - Week Ahead

Read more
18 Feb 2015 16:21

UK AGM, EGM Calendar - Week Ahead

Read more
18 Feb 2015 06:16

UK AGM, EGM Calendar - Week Ahead

Read more
17 Feb 2015 16:08

UK AGM, EGM Calendar - Week Ahead

Read more
17 Feb 2015 06:16

UK AGM, EGM Calendar - Week Ahead

Read more
16 Feb 2015 16:02

UK AGM, EGM Calendar - Week Ahead

Read more
16 Feb 2015 06:16

UK AGM, EGM Calendar - Week Ahead

Read more
13 Feb 2015 15:58

UK AGM, EGM Calendar - Week Ahead

Read more
13 Feb 2015 06:15

UK AGM, EGM Calendar - Week Ahead

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.